Literature DB >> 16354559

High risk populations and HIV-1 infection in China.

Tuo Fu Zhu1, Chun Hui Wang, Peng Lin, Na He.   

Abstract

China is currently experiencing one of the most rapidly expanding HIV epidemics in the world. Although the overall prevalence rate is still low, with a population of 1.3 billion, high-risk factors which have contributed to the HIV/AIDS epidemics worldwide continue to prevail in China, including a high rate of injecting drug use and needle sharing, commercial sex with low rates of condom use, and concurrent sex with both commercial sex workers and non-commercial casual or steady sex partners. In addition, there are increasing "double risk" populations overlapping drug users and sex workers, as well as increasing rates of STDs and HIV among high-risk populations. Sexual transmission, therefore, may serve as a bridge connecting high-risk populations with general populations. There is an urgent need to prevent the spread of HIV from these high-risk populations into the general population of China.

Entities:  

Mesh:

Year:  2005        PMID: 16354559     DOI: 10.1038/sj.cr.7290358

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  12 in total

1.  Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China.

Authors:  T D Ngo; O Laeyendecker; C Li; H Tai; M Cui; S Lai; T C Quinn
Journal:  Int J STD AIDS       Date:  2008-10       Impact factor: 1.359

2.  Prevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China.

Authors:  Haibo Wang; Ray Y Chen; Guowei Ding; Yanling Ma; Jianguo Ma; Jin Hua Jiao; Zhenglai Wu; Gerald B Sharp; Ning Wang
Journal:  Int J Infect Dis       Date:  2008-08-20       Impact factor: 3.623

3.  Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data.

Authors:  Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Kamyar Arasteh; Bradley M Mathers; Louisa Degenhardt; Holly Hagan
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

4.  Male rural-to-urban migrants and risky sexual behavior: a cross-sectional study in Shanghai, China.

Authors:  Jun-Qing Wu; Ke-Wei Wang; Rui Zhao; Yu-Yan Li; Ying Zhou; Yi-Ran Li; Hong-Lei Ji; Ming Ji
Journal:  Int J Environ Res Public Health       Date:  2014-03-10       Impact factor: 3.390

5.  Measuring HIV stigma at the family level: psychometric assessment of the Chinese Courtesy Stigma Scales (CCSSs).

Authors:  Hongjie Liu; Yongfang Xu; Yehuan Sun; Levent Dumenci
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

6.  Multiple sex partner behavior in female undergraduate students in China: a multi-campus survey.

Authors:  Hong Yan; Weiqi Chen; Haocheng Wu; Yongyi Bi; Miaoxuan Zhang; Shiyue Li; Kathryn L Braun
Journal:  BMC Public Health       Date:  2009-08-22       Impact factor: 3.295

7.  Survey of motivation for use of voluntary counseling and testing services for HIV in a high risk area of Shenyang, China.

Authors:  Ling Zhou; Junqiao Guo; Lijuan Fan; Jing Tian; Baosen Zhou
Journal:  BMC Health Serv Res       Date:  2009-02-05       Impact factor: 2.655

8.  Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?

Authors:  Mirjam Kretzschmar; Weidong Zhang; Rafael T Mikolajczyk; Lan Wang; Xinhua Sun; Alexander Kraemer; Fan Lv
Journal:  BMC Infect Dis       Date:  2008-08-04       Impact factor: 3.090

9.  Seropositivity and risk factors for herpes simplex virus type 2 infection among female sex workers in Guangxi, China.

Authors:  Shaochun Chen; Yueping Yin; Xiangsheng Chen; Hongchun Wang; Yanhua Yu; Wanhui Wei; Yan Han; Ning Jiang; Baoxi Wang
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

10.  Unmarried male migrants and sexual risk behavior: a cross-sectional study in Shanghai, China.

Authors:  Ke-Wei Wang; Jun-Qing Wu; Hong-Xin Zhao; Yu-Yan Li; Rui Zhao; Ying Zhou; Hong Lei Ji
Journal:  BMC Public Health       Date:  2013-12-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.